Department of Community Health; include continuous glucose monitors as a pharmacy benefit for Medicaid recipients; require
Impact
If passed, SB109 would amend existing laws related to insurance and medical assistance in Georgia. It would enhance the extent of health benefits provided under Medicaid, aligning with the evolving standards of care for diabetes management. By mandating CGMs as a covered benefit, the bill aims to significantly improve health outcomes for patients who rely on these devices for daily management of their condition. Moreover, the bill may impact how insurers operate, reinforcing patient rights to choose their healthcare providers without added financial burden from the insurer.
Summary
Senate Bill 109 (SB109) focuses on improving access to healthcare for patients, particularly those managing diabetes. The bill mandates that Medicaid cover continuous glucose monitors (CGMs) as a benefit starting July 1, 2023. This is particularly important as CGMs provide critical data for diabetes management, potentially reducing complications associated with the disease. Additionally, the bill prohibits health insurers from discriminating against healthcare providers in terms of how provider administered drugs are procured, delivered, and administered, ensuring better access for patients to necessary medications.
Sentiment
Overall sentiment towards SB109 appears largely positive among healthcare advocates and providers, given its focus on patient welfare and access to essential medical devices. Proponents argue that the accessibility of continuous glucose monitors will substantially benefit diabetic patients, providing them with necessary tools for effective health management. However, there may be concerns regarding the financial implications for insurance companies and potential legislative pushback on the restrictions placed on their operations.
Contention
While the bill is aimed at enhancing patient care, it may present challenges in implementation for insurers who may need to adjust their coverage protocols to comply with the new regulations. Concerns may also arise regarding the balance of state regulation on healthcare provisions versus the autonomy of insurance companies. These points of contention signal a larger ongoing debate about how best to structure healthcare benefits in a manner that is both equitable and economically viable for all stakeholders involved.
Requires health insurance plans to provide coverage for continuous blood glucose monitors for all children; requires coverage for glucose monitoring devices for all sugar disorders.
Requires health insurance plans to provide coverage for continuous blood glucose monitors for all children; requires coverage for glucose monitoring devices for all sugar disorders.
Creates the healthcare worker platform act that requires platforms offering healthcare shifts to register with the Rhode Island department of health while exempting them from being classified as nursing service agencies.
Requires insurers to pay electronic claims for healthcare coverage within 14 calendar days of receipt. Permits healthcare providers to dispute claim denials within 60 days and empowers the secretary of EOHHS to establish penalties for violations.
To Prohibit Healthcare Insurers From Exercising Recoupment For Payment Of Healthcare Services More Than One Year After The Payment For Healthcare Services Was Made.